Editorial: CD4+ T cells in HIV: A Friend or a Foe?

Front Immunol. 2023 Jul 11:14:1203531. doi: 10.3389/fimmu.2023.1203531. eCollection 2023.

Sakthivel Govindaraj^{1

2}, Hemalatha Babu^{1

2}, Sunil Kannanganat³, Monica Vaccari^{4

5}, Constantinos Petrovas⁶, Vijayakumar Velu^{1

2}

¹ Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.
² Division of Microbiology and Immunology, Emory Vaccine Center, Emory University, Atlanta, GA, United States.
³ Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States.
⁴ Division of Immunology, Tulane National Primate Research Center, Covington, LA, United States.
⁵ Department of Microbiology and Immunology, Tulane School of Medicine, New Orleans, LA, United States.
⁶ Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

No abstract available

Keywords: CD4+ T cells; HIV; HIV cure; follicular T helper cells; reservoirs.

Publication types